DEALS
Zhong Lun Assisted Beijing Konruns Pharmaceutical Co., Ltd. with the Acquisition of NT Pharma International Company Limited
Zhong Lun Assisted Beijing Konruns Pharmaceutical Co., Ltd. with the Acquisition of NT Pharma International Company Limited
On September 4, 2020, Beijing Konruns Pharmaceutical Co., Ltd. (603590.SH) (“Konruns") announced that it has paid the 1st installment for the acquisition of 100% equity interest in NT Pharma International Company Limited (a company registered in Hong Kong) (the “Project") following completion of its business restructure, and has completed the formalities for the share transfer. The purpose of this project is to acquire the relevant rights and interests in Miacalcic-related assets and business and the total consideration is RMB 900 million.
Zhong Lun Law Firm acted for Konruns on this project and provided comprehensive legal services, including advising on the transaction structure from the perspective of the laws of multiple jurisdictions and preparing the cross-border acquisition plan, conducting legal due diligence on the assets of the target company in about 20 jurisdictions, providing legal opinions on the licensing and regulatory issues of drug manufacturing and distribution in Mainland China, Hong Kong and various overseas jurisdictions, preparing, reviewing and negotiating on the transaction documents, advising on outbound remittance of funds from Mainland China and cross border security, and assisting with the completion.
The legal team of Zhong Lun for this Project is led by partners Qixiang ZHANG and Wayne WANG. Qixiang ZHANG is responsible for providing Mainland China legal advices, and Wayne WANG is responsible for providing and coordinating overseas legal services (the project involves about 20 jurisdictions including Hong Kong, Switzerland, USA, BVI, Cayman, France, Germany). The major team members include associates Junge CHENG, Jolie XU and Weiyi TIAN.
As a local high-tech pharmaceutical enterprise and a listed company in China, Konruns has a comprehensive R&D system and a mature R&D team with international first-class standards. Konruns has won many top-tier honors in China, such as the National High-tech R&D Program (863 Program), China Torch Program and China Patent Award.
